Biofrontera
BFRI
16 hedge funds and large institutions have $900K invested in Biofrontera in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 4 closing their positions.
900% more call options, than puts
Call options by funds: $10K | Put options by funds: $1K
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
7% more funds holding
Funds holding: 15 → 16 (+1)
4.87% less ownership
Funds ownership: 8.49% → 3.63% (-4.9%)
70% less capital invested
Capital invested by funds: $3.01M → $900K (-$2.11M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$19K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$11.8K |
| 3 |
BlackRock
New York
|
+$10.7K |
| 4 |
Jane Street
New York
|
+$6.64K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$6.47K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$1.42M |
| 2 |
Two Sigma Advisers
New York
|
-$30K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$13.7K |
| 4 |
BA
Bard Associates
Chicago,
Illinois
|
-$8.2K |
| 5 |
Citigroup
New York
|
-$1K |
BFRI Hedge Fund Activity: Q3 2022 in Review
16 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRI) for Q3 2022, worth a combined $900K — down 70% from $3.01M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new BFRI positions and 4 closed out — a net gain of 1 holder — while 4 added to existing stakes and 3 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $19K. The largest seller was Armistice Capital, exiting entirely with an estimated $1.42M sold.
- 16 institutional investors held Biofrontera (BFRI) as of Q3 2022, up from 15 in Q2 2022.
- Funds reported $900K of Biofrontera stock for Q3 2022, down 70% quarter-over-quarter.
- 5 funds opened new Biofrontera positions in Q3 2022 and 4 closed out, a net change of +1 holder.
- The largest Biofrontera buyer in Q3 2022 was Renaissance Technologies, an estimated $19K added.
- The largest Biofrontera seller in Q3 2022 was Armistice Capital, an estimated $1.42M sold.
Based on aggregated 13F filings for Q3 2022.